Additional file 4: Table S2. of Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer

Pre-diagnostic analysis of combined anticoagulant drug usage stratified by number of Defined Daily Doses (DDD), duration and intensity of usage. Age-adjusted and multivariable-adjusted hazard ratios (95% CI) related to all PCa deaths. Table S3. Post-diagnostic results for combined anticoagulant usage. Age-adjusted, multivariable-adjusted and lag-time hazard ratios (95% CI) related to all PCa deaths. (DOCX 405 kb)